Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

TP53 Action and the Consequences of TP53 Mutation in Acute Myeloid Leukemia

Scott W. Lowe, PhD

Blood (2019) 134 (Supplement_1): SCI-13.

https://doi.org/10.1182/blood-2019-121285

Published: 2019

Journal Articles

Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome

Jason R Schwartz, MD PhD, Jing Ma, PhD, Michael P Walsh, PhD, Xiaolong Chen, PhD, Tamara Lamprecht, BS, Jennifer Kamens, MD, Scott Newman, PhD, Jinghui Zhang, PhD, Tanja A. Gruber, MD PhD, Xiaotu Ma, Jeffery M. Klco, MD PhD

Blood (2019) 134 (Supplement_1): 1394.

https://doi.org/10.1182/blood-2019-128665

Published: 2019

Journal Articles

Distinct Implications of TP53 Hits for Patients with Treatment-Related MDS and AML

Teodora Kuzmanovic, Bhumika J. Patel, MD, Yasunobu Nagata, Hassan Awada, MD, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Srinivasa Reddy Sanikommu, MD, Louis Williams, MD MBA, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4353.

https://doi.org/10.1182/blood-2018-99-120059

Published: 2018

Journal Articles

Clinical Impact of Clonal Hematopoiesis after Autologous Stem Cell Transplantation for Lymphoma: A National Population-Based Cohort Study

Blood (2018) 132 (Supplement 1): 607.

https://doi.org/10.1182/blood-2018-99-109893

Published: 2018

Journal Articles

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Blood (2018) 132 (Supplement 1): 747.

https://doi.org/10.1182/blood-2018-99-119530

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Richard Dillon, MA, PhD MRCP, FRCPath, Jelena Jovanovic, PhD, Nicola Potter, PhD, Nicola Foot, MSc, Matthew J Ahearne, MD MBBS, Sandrine Jayne, PhD, Michael Dennis, MD MRCP, FRCPath, Ann E. Hunter, MBBS, FRCP, FRCPath, Martin J.S. Dyer, Paresh Vyas, Lynn Quek, FRCPath, DPhil, MBBS, Nigel H. Russell, Robert K. Hills, MA, DPhil, MSc, Ellen Solomon, PhD, David Grimwade, PhD MRCP, MRCPath

Blood (2018) 132 (Supplement 1): 2570.

https://doi.org/10.1182/blood-2018-99-114233

Published: 2018

Journal Articles

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Jason R Schwartz, MD PhD, Michael P Walsh, PhD, Jing Ma, PhD, Tamara Lamprecht, B.S., Raul C Ribeiro, MD, Jeffery M. Klco, MD PhD

Blood (2018) 132 (Supplement 1): 2775.

https://doi.org/10.1182/blood-2018-99-118995

Published: 2018

Journal Articles

Clonal Evolution of Therapy-Related Myeloid Neoplasm Analyzed Sequentially By Targeted Deep Sequencing Using Bone Marrow Cells

Katagiri Seiichiro, MD PhD, Kenko Azuma, PhD, Yuu Saitoh, MD, Seiichiro Yoshizawa, MD PhD, Daigo Akahane, MD PhD, Hiroaki Fujimoto, MD, Yoshikazu Ito, MD PhD, Tomohiro Umezu, PhD, Junko.H Ohyashiki, MD PhD, Kazuma Ohyashiki, MD PhD

Blood (2018) 132 (Supplement 1): 5525.

https://doi.org/10.1182/blood-2018-99-113317

Published: 2018

Journal Articles

Somatic Mutations in Therapy-Related Myeloid Neoplasms Are Influenced By Therapeutic Modality and Clonal Hematopoiesis of Indeterminate Potential

Teodora Kuzmanovic, Bhumika J. Patel, MD, Srinivasa Reddy Sanikommu, MD, Yasunobu Nagata, Hassan Awada, MD, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Remco J Molenaar, MD PhD, Babal K. Jha, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, Tomas Radivoyevitch, PhD

Blood (2018) 132 (Supplement 1): 3084.

https://doi.org/10.1182/blood-2018-99-119950

Published: 2018

Journal Articles

Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT

Gerbrig Berger, Leonie I. Kroeze, Theresia N. Koorenhof-Scheele, Aniek O. de Graaf, Kenichi Yoshida, Hiroo Ueno, Yuichi Shiraishi, Satoru Miyano, Eva van den Berg, Hein Schepers, Bert A. van der Reijden, Seishi Ogawa, Edo Vellenga, Joop H. Jansen

Blood (2018) 131 (16): 1846–1857.

https://doi.org/10.1182/blood-2017-09-805879

Published: 2018

Includes: Supplemental data

Journal Articles

PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms

Reem Elagooz, MS, MD, Mai Aly, MD MS, Cassandra M. Hirsch, BS, Bartlomiej P. Przychodzen, MSc, Teodora Kuzmanovic, BA, Tomas Radivoyevitch, Valeria Visconte, PhD, Sudipto Mukherjee, MD PhD MPH, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Jaroslaw P. Maciejewski, PhD MD FACP, Yasunobu Nagata, MD PhD

Blood (2017) 130 (Supplement 1): 4233.

https://doi.org/10.1182/blood.V130.Suppl_1.4233.4233

Published: 2017

Journal Articles

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Ali Alahmari, MD, Jeffrey H. Lipton, MD PhD, Dennis Kim, MD

Blood (2017) 130 (Supplement 1): 2880.

https://doi.org/10.1182/blood.V130.Suppl_1.2880.2880

Published: 2017

Journal Articles

Chemotherapy and Radiation Results in Distinct Patterns of Somatic Mutations in Subsequent Myeloid Disease

Teodora Kuzmanovic, BA, Tomas Radivoyevitch, PhD, Srinivasa Reddy Sanikommu, MD, Bhumika J. Patel, MD, Yasunobu Nagata, MD PhD, Cassandra M. Hirsch, BS, Bartlomiej P. Przychodzen, MSc, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aziz Nazha, MD, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1673.

https://doi.org/10.1182/blood.V130.Suppl_1.1673.1673

Published: 2017

Journal Articles

Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease

Alan H. Shih, MDPhD, Franck Rapaport, PhD, Stephen S. Chung, MD, Emily K Dolezal, Sean Hobson, MA, Mary K Amato, Christopher Y. Park, MD PhD, Mikkael A. Sekeres, MD MS, Marcel R.M. van den Brink, MD PhD, Stephen Nimer, MD, Ross L. Levine, MD, Jaroslaw P. Maciejewski, MD PhD, Virginia M. Klimek, MD

Blood (2014) 124 (21): 4611.

https://doi.org/10.1182/blood.V124.21.4611.4611

Published: 2014

Journal Articles

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Deregulation of Key Biological Pathways in Therapy-Related Myeloid Neoplasms

Orsolya Lautner-Csorba, PhD, Jason Sotzen, Fabiani Emiliano, Fianchi Luana, Stefan Hohaus, MD, Giuseppe Leone, MD, Maria Teresa Voso, Maria E Figueroa, MD

Blood (2014) 124 (21): 3542.

https://doi.org/10.1182/blood.V124.21.3542.3542

Published: 2014

Journal Articles

Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study

Thomas Prebet, MD, PhD, Zhuoxin Sun, PhD, Rhett Ketterling, MD, Peter L. Greenberg, MD, Amer M. Zeidan, MD, Mark R. Litzow, MD, Janice L. Gabrilove, MD, Harry Paul Erba, MD, PhD, Elisabeth Paietta, PhD, Magdalena Czader, MD, PhD, Steven D Gore, Martin S Tallman, MD

Blood (2013) 122 (21): 2777.

https://doi.org/10.1182/blood.V122.21.2777.2777

Published: 2013

Journal Articles

High Incidence of tMDS in Elderly Lymphoma Patients Subjected to Radioimmunotherapy

Dagmara Zimowska-Curylo, Wojciech Jurczak, Agnieszka Giza, Malgorzata Jakobczyk, Katarzyna Krawczyk, Aleksander B Skotnicki

Blood (2012) 120 (21): 4882.

https://doi.org/10.1182/blood.V120.21.4882.4882

Published: 2012

NARROW

TP53 Action and the Consequences of TP53 Mutation in Acute Myeloid Leukemia

Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome

Distinct Implications of TP53 Hits for Patients with Treatment-Related MDS and AML

Clinical Impact of Clonal Hematopoiesis after Autologous Stem Cell Transplantation for Lymphoma: A National Population-Based Cohort Study

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Clonal Evolution of Therapy-Related Myeloid Neoplasm Analyzed Sequentially By Targeted Deep Sequencing Using Bone Marrow Cells

Somatic Mutations in Therapy-Related Myeloid Neoplasms Are Influenced By Therapeutic Modality and Clonal Hematopoiesis of Indeterminate Potential

Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT

PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Chemotherapy and Radiation Results in Distinct Patterns of Somatic Mutations in Subsequent Myeloid Disease

Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Deregulation of Key Biological Pathways in Therapy-Related Myeloid Neoplasms

Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study

High Incidence of tMDS in Elderly Lymphoma Patients Subjected to Radioimmunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only